1st part of COVAXIN phase-I trials completed, results encouraging: Chief investigator

The first part of phase-I of COVAXIN human trials was completed on Saturday at the Post-Graduate Institute of Medical Sciences, Rohtak, said Savita Verma, principal investigator of the vaccine trial team. "The results were encouraging. Six people were administered vaccine on Saturday under the second part of phase-I," she told ANI. The human trials began at PGIMS Rohtak on July 17.